Reaktionsgleichung
[CH3:1][C:2]([CH3:17])([CH3:16])[C@@H:3]([C:13]([OH:15])=[O:14])[NH:4][C:5]([O:7][CH2:8][CH2:9][CH2:10][CH:11]=[CH2:12])=[O:6].Cl.N[C@@H:20]([C:24]1(C)CCCCC1)[C:21](O)=O>>[CH3:1][C:2]1([C@H:3]([NH:4][C:5]([O:7][CH2:8][CH2:9][CH2:10][CH:11]=[CH2:12])=[O:6])[C:13]([OH:15])=[O:14])[CH2:17][CH2:24][CH2:20][CH2:21][CH2:16]1Komponenten
3
Versuchsvorschrift
(2S)-(1-methylcyclohexyl) {[(pent-4-en-1-yloxy)carbonyl]amino}acetic acid was prepared according to the procedure for 3-methyl-N-[(pent-4-enyloxy)carbonyl]-L-valine by using (2S)-amino(1-methylcyclohexyl)acetic acid-HCl instead of t-butylglycine. LRMS (ESI) m/z 347.3 [(M+Na+CH3CN)+; calcd for C17H28N2NaO4: 347.2].
Quellen und Nachweise
- ORD-Eintrag
- ord-40b8aebf6d084ccd9a514e4a1a1c5c61
- Quelldatensatz
- uspto-grants-2012_07
- Patentnummer
- US08216999B2
Verknüpfte Notizen
Wird geladen…